Fact CheckerSign in

NCT07499986Not yet recruiting

Respiratory Muscle Training in Patients Undergoing Lung Cancer Surgery

Source: ClinicalTrials.gov · Last updated 30 Mar 2026

Brief summary (registry, in English)

This randomized, controlled, double-blind clinical trial aims to investigate the effectiveness of preoperative inspiratory muscle training (IMT) and expiratory muscle training (EMT) in patients scheduled for lung cancer surgery. Respiratory muscle dysfunction contributes to postoperative pulmonary complications (PPCs), prolonged hospitalization, and reduced functional recovery. Although IMT has been evaluated in several studies, the evidence is limited and heterogeneous, and the effectiveness of EMT in this population has never been studied. This study will compare conventional preoperative physiotherapy alone with physiotherapy combined with IMT or EMT to determine their impact on postoperative clinical outcomes, respiratory muscle function, and exercise capacity.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
70 (estimated)
First submitted
27 Nov 2025
Start date
30 Dec 2026
Primary completion date
30 Dec 2026
Lead sponsor
Saglik Bilimleri Universitesi
Diseases
Lung cancer
NCT number
NCT07499986

What you commit to

  • Study type: Interventional
  • Planned participants: 70
  • From 30 Dec 2026 to the primary completion date, 30 Dec 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of a cardiac disease that affects quality of life (ASA II or better is required)
  • Presence of severe cognitive problems or psychiatric disorders
  • Presence of physical limitations (e.g., visual or hearing impairment, orthopedic problems)
  • If the lung cancer diagnosis is not confirmed after frozen section or wedge resection, the patient will be removed from the study

Who the study is looking for

  • Diagnosis of lung cancer staged IA to IIIB based on clinical staging
  • Planned to undergo surgery via thoracotomy or videothoracoscopy (VATS)
  • Having a smartphone and being capable of performing video call

Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Saglik Bilimleri Universitesi
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.